J M Bryant
Overview
Explore the profile of J M Bryant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bryant J, Cruz-Chamorro R, Gan A, Liveringhouse C, Weygand J, Nguyen A, et al.
Commun Med (Lond)
. 2024 May;
4(1):96.
PMID: 38778215
Background: Definitive local therapy with stereotactic ablative radiation therapy (SABR) for ultracentral lung lesions is associated with a high risk of toxicity, including treatment related death. Stereotactic MR-guided adaptive radiation...
2.
Bryant J, Madey K, Rosenberg S, Frakes J, Hoffe S
J Cancer Educ
. 2024 May;
39(6):713-720.
PMID: 38761305
Leading successful change efforts first requires assessment of the "before change" environment and culture. At our institution, the radiation oncology (RO) residents follow a longitudinal didactic learning program consisting of...
3.
Naghavi A, Bryant J, Kim Y, Weygand J, Redler G, Sim A, et al.
BMC Cancer
. 2024 Apr;
24(1):437.
PMID: 38594603
Background: Soft tissue sarcomas (STS), have significant inter- and intra-tumoral heterogeneity, with poor response to standard neoadjuvant radiotherapy (RT). Achieving a favorable pathologic response (FPR ≥ 95%) from RT is...
4.
Bryant J, Palm R, Herrera R, Rubens M, Hoffe S, Kim D, et al.
Cancer Control
. 2023 Jan;
30:10732748221150228.
PMID: 36598464
Purpose: Treatment options for pancreatic ductal adenocarcinoma (PDAC) are commonly limited for patients with advanced age due to medical comorbidities and/or poor performance status. These patients may not be candidates...
5.
Bryant J, Palm R, Liveringhouse C, Boyer E, Hodul P, Malafa M, et al.
Adv Radiat Oncol
. 2022 Nov;
7(6):101045.
PMID: 36420193
Purpose: Preoperative radiation therapy (RT) for pancreatic adenocarcinoma reduces positive surgical margin rates, and when delivered to an ablative dose range it may improve local control and overall survival for...
6.
DiLillo D, Weinberg J, Yoshizaki A, Horikawa M, Bryant J, Iwata Y, et al.
Leukemia
. 2012 Jun;
27(1):170-82.
PMID: 22713648
Chronic lymphocytic leukemia (CLL) can be immunosuppressive in humans and mice, and CLL cells share multiple phenotypic markers with regulatory B cells that are competent to produce interleukin (IL)-10 (B10...
7.
8.
Tran S, Wang J, Bandyopadhyay B, Redman R, Dutra A, Pak E, et al.
Tissue Eng
. 2005 Mar;
11(1-2):172-81.
PMID: 15738672
Therapeutic irradiation for head and neck cancer, and the autoimmune disease Sjogren's syndrome, lead to loss of salivary parenchyma. They are the two main causes of irreversible salivary gland hypofunction....
9.
Bryant J
Br J Sociol
. 2000 Oct;
51(3):489-523.
PMID: 11038134
Critics of the interdisciplinary enterprise of historical sociology commonly contend that the narrational accounts of past social phenomena provided by historians are inadequate to the task of theory-building and testing....
10.
Luzio J, Bryant J, Taylor P
Clin Chim Acta
. 1998 Jan;
266(1):13-22.
PMID: 9435984
Carbohydrate residues covalently linked to plasma membrane proteins and lipids often provide specific markers at the cell surface. Traditionally such carbohydrate structures have been identified using antibodies and lectins. However...